Kim Kee Won, Yoon Chong Hyeon, Kay Chul Seung, Kim Hee Jung, Suh Kwang-Sun, Kim Suk Young, Park Suk Young
Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
J Korean Med Sci. 2003 Apr;18(2):287-9. doi: 10.3346/jkms.2003.18.2.287.
Nephrotic syndrome has been described as one of the clinical forms of chronic graft-versus-host disease (cGVHD), but a limited number of cases have been described. We experienced a young female patient with nephrotic syndrome developed 22 months after allogeneic hematopoietic stem cell transplantation (HSCT) for severe aplastic anemia. She had been well after successful management for gut-limited cGVHD until she developed a clinical nephrotic syndrome with hypoalbuminemia of 2.0 g/dL and 24-hr urine protein of 6.88 g/dL. On physical examination and laboratory findings, there was no other evidence of cGVHD. Clinical and renal biopsy findings were consistent with cGVHD-related membranous nephropathy, and immunosuppressive agents with cyclosporine and prednisone were prescribed. After 3 month of treatment, the proteinuria decreased to normal range; and the patient from nephrotic syndrome nearly recovered. We recommend cGVHD-related glomerulonephritis should be considered in all patients with hypoalbuminemia following allogeneic HSCT, even if there is no other evidence of clinical GVHD.
肾病综合征已被描述为慢性移植物抗宿主病(cGVHD)的临床形式之一,但相关病例报道较少。我们遇到一名年轻女性患者,她在接受异基因造血干细胞移植(HSCT)治疗严重再生障碍性贫血22个月后出现了肾病综合征。在成功治疗肠道局限性cGVHD后,她一直状况良好,直到出现临床肾病综合征,血清白蛋白水平降至2.0 g/dL,24小时尿蛋白为6.88 g/dL。体格检查和实验室检查结果显示,没有其他cGVHD的证据。临床和肾活检结果符合cGVHD相关的膜性肾病,遂给予环孢素和泼尼松等免疫抑制剂治疗。治疗3个月后,蛋白尿降至正常范围;该患者的肾病综合征几乎痊愈。我们建议,对于所有异基因HSCT后出现低白蛋白血症的患者,即使没有其他临床GVHD的证据,也应考虑cGVHD相关的肾小球肾炎。